AIDS 2022 Conference Review

In this review:
  -  Long-acting cabotegravir
  -  Bictegravir/emtricitabine/tenofovir alafenamide vs dolutegraivr/ emtricitabine/tenofovir disoproxil fumarate in HIV/HBV co-infections
  -  Doxycycline for STI prevention in MSM and transgender women on HIV PrEP or living with HIV
  -  Combining immuno-therapeutic agents for ARV-free remission of HIV
  -  Breast is best? Making infant feeding options available for all women living with HIV
  -  Heart health and ageing on ART
  -  Monkeypox: Outbreak and response in non-endemic countries
  -  Monoclonal antibody VRC01 with antiretroviral therapy to promote clearance of HIV-1 in infants
  -  Tuberculosis screening using X-ray diagnosis and novel urine lipoarabinomannan assay in HIV
  -  New drugs for HIV

Please login below to download this issue (PDF)